Blood-based Genomic and Cellular Determinants of Response to Neoadjuvant PD-1 Blockade in Patients with Non-Small-Cell Lung Cancer
Xi Zhang, Rui Chen, Wenqing Li, Shengchao Zhang, Mengju Jiang, Guodong Su, Yuru Liu, Yu Cai, Wuhao Huang, Yuyan Xiong, Shengguang Wang
The paper identifies blood-based genomic and cellular biomarkers predictive of response to neoadjuvant PD-1 blockade in NSCLC patients using transcriptomic and mutation analysis.
medRxiv · Dec 7, 2021 · PreprintGenetic & Genomic Medicine